A decrease in CALM1 has been reported for CD4+ TIL in breast cancer, and CALM3 expression in TIL has been shown to be higher in extensively infiltrated tumors vs minimally infiltrated tumors suggesting a possible association between CaM levels and tumor infiltrating abilities of T cells (Gu-Trantien et al., 2013). Here, CALM3 is linked to breast carcinoma.